Impact of tobacco smoke on interleukin-16 protein in human airways, lymphoid tissue and T lymphocytes

Clinical and Experimental Immunology

Volumn 138, Issue 1, 2004, Pages 75-82

  Andersson, Anders ^a,c   Qvarfordt, I ^a   Laan, M ^a   Sjostrand M ^a   Malmhall C ^a   Riise, G C ^a   Cardell, L O ^b   Linden A ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

BAL; CD4+; CD8+; Chronic bronchitis; Tonsil

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 16; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ADULT; AIRWAY; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LUNG LAVAGE; LYMPHOCYTE SUBPOPULATION; LYMPHOID TISSUE; MALE; PALATINE TONSIL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; T LYMPHOCYTE; TOBACCO;

ADULT; AGED; BRONCHITIS; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-16; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOID TISSUE; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN; RNA, MESSENGER; SMOKE; T-LYMPHOCYTES; TOBACCO; TONSIL;

EID: 4644232834     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02580.x     Document Type: Article

References (23)

1. Turato G, Zuin R, Miniati M et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am J Respir Crit Care Med 2002; 166:105-110.
2. Kim WD, Kim WS, Koh Y et al. Abnormal peripheral blood T-lymphocyte subsets in a subgroup of patients with COPD. Chest 2002; 122:437-444.
3. Center DM, Cruikshank W. Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J Immunol 1982; 128:2563-2568.
4. Berman JS, Cruikshank WW, Center DM, Theodore AC, Beer DJ. Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset. Cell Immunol 1985; 95:105-112.
5. Van Epps DE, Potter JW, Durant DA. Production of a human T lymphocyte chemotactic factor by T cell subpopulations. J Immunol 1983; 130:2727-2731.
6. de Bie JJ, Henricks PA, Cruikshank WW, Hofman G, Nijkamp FP, van Oosterhout AJ. Effect of interleukin-16-blocking peptide on parameters of allergic asthma in a murine model. Eur J Pharmacol 1999; 383:189-196.
7. + T cells by IL-16 and IL-2. J Immunol 1998; 160:2115-220.
8. Laan M, Qvarfordt I, Riise GC, Andersson BA, Larsson S, Linden A. Increased levels of interleukin-16 in the airways of tobacco smokers: relationship with peripheral blood T lymphocytes. Thorax 1999; 54:911-916.
9. + T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:822-826.
10. Saetta M, Mariani M, Panina-Bordignon P et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 165:1404-1409.
11. Qvarfordt I, Riise GC, Andersson BA, Larsson S. Lower airway bacterial colonization in asymptomatic smokers and smokers with chronic bronchitis and recurrent exacerbations. Respir Med 2000; 94:881-887.
12. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:S77-121.
13. Boman G, Backer U, Larsson S, Melander B, Wahlander L. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis 1983; 64:405-415.
14. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report of the Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:5-40.
15. Su Y, Han W, Giraldo C, De Li Y, Block ER. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 1998; 19:819-825.
16. Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 1990; 113:619-627.
17. Salvi S, Semper A, Blomberg A et al. Interleukin-5 production by human airway epithelial cells. Am J Respir Cell Mol Biol 1999; 20:984-991.
18. Laan M, Linden A, Riise GC. IL-16 in the airways of lung allograft recipients with acute rejection or obliterative bronchiolitis. Clin Exp Immunol 2003; 133:290-296.
19. Klimiuk PA, Goronzy JJ, Weyand CM. IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis. J Immunol 1999; 162:4293-4299.
20. Higashimoto Y, Shimada Y, Fukuchi Y et al. Inhibition of mouse alveolar macrophage production of tumor necrosis factor alpha by acute in vivo and in vitro exposure to tobacco smoke. Respiration 1992; 59:77-80.
21. + T cells is activation dependent. J Immunol 1999; 162:1287-1293.
22. Moore K. Clinically oriented anatomy. Baltimore: Williams & Wilkins, 1992:834-835.
23. Kramer MF, Mack B, Rasp G. Immunohistological expression of interleukin 16 in human tonsils. Arch Otolaryngol Head Neck Surg 2001; 127:1120-1125.